84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Radiation Oncology Market to hit US$ 19.2 Billion by 2032, Expanding Rapidly at a CAGR of 9.1%: Market.us Report
May 24, 2023 09:44 ET | Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- It is anticipated that the Radiation oncology industry may increase from US$ 8.2 billion in 2023 to US$ 19.2 billion by 2032. Between 2022 and 2032, the...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Tumor Ablation Market size to grow by US$ 4,389 Million by 2032, North America to account for 37% of the market growth - Market.us
May 24, 2023 05:28 ET | Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- The tumor ablation market size reached US$ 1,333 Million in 2022. Looking forward, Market.us expects the market to reach US$ 4,389 Million by 2032,...
DBMR Logo.png
Cancer Treatment Market to Grasp Outstanding Growth of USD 524,921.84 Million by 2029, Size, Share, Trends, Key Drivers, Growth Opportunities and Competitive Outlook
May 23, 2023 07:30 ET | Data Bridge Market Research
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has released a new report titled "Cancer Treatment Market" which delves deep into growth strategies, drivers, opportunities,...
Elevar Logo for Common Use.png
Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma
May 17, 2023 07:00 ET | Elevar Therapeutics
FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a wholly owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
MicrosoftTeams-image (5).png
Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report
May 11, 2023 06:30 ET | Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report...
MicrosoftTeams-image (5).png
Mice Model Market to Reach USD 2.3 Bn Growing at a CAGR of 6.2% from 2021 to 2028 – Global Analysis by Transparency Market Research
May 02, 2023 08:30 ET | Transparency Market Research
Wilmington, Delaware, United States, May 02, 2023 (GLOBE NEWSWIRE) -- The global mice model market stood at USD 1.5 billion in 2020 and the global market is projected to reach USD 2.3 billion by...
Elevar Logo for Common Use.png
Elevar Therapeutics Presents AACR 2023 Poster Demonstrating Rivoceranib as Most Selective VEGFR-2 Inhibitor When Compared to Other TKIs With Known Activity Against VEGFR-2
April 18, 2023 09:00 ET | Elevar Therapeutics
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001
March 28, 2023 03:45 ET | AKAMPION
-   Novel compound for targeted tumor therapy to be evaluated in patients with soft tissue sarcoma-   First patients to be enrolled in Q2, 2023 Munich, Germany – March 28, 2023 – Thermosome, a...
Jowin Shinhan Securities IPO
Jowin, the Apple in Korea’s cancer treatment, expands their business globally
February 21, 2023 06:06 ET | JOWIN
Korea's innovative venture company Jowin declares its expansion into the global cancer care market through the establishment of a global telemedicine platform.A telemedicine platform for overseas...
FBI LOGO TM.png
Pancreatic Cancer Treatment Market Exhibits 15.7% CAGR to Hit USD 6.85 Billion by 2029
February 20, 2023 07:04 ET | Fortune Business Insights
Pune, India, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The global pancreatic cancer treatment market size was worth USD 2.15 billion in 2021 and is slated to rise from USD 2.48 billion in 2022 to USD 6.85...